These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11897434)

  • 1. Clinical benefits of low serum digoxin concentrations in heart failure.
    Adams KF; Gheorghiade M; Uretsky BF; Patterson JH; Schwartz TA; Young JB
    J Am Coll Cardiol; 2002 Mar; 39(6):946-53. PubMed ID: 11897434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a simplified nomogram to individualize digoxin dosing versus standard dosing practices in patients with heart failure.
    DiDomenico RJ; Bress AP; Na-Thalang K; Tsao YY; Groo VL; Deyo KL; Patel SR; Bishop JR; Bauman JL
    Pharmacotherapy; 2014 Nov; 34(11):1121-31. PubMed ID: 25164709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of digoxin in reducing one-year mortality in chronic heart failure in the Digitalis Investigation Group trial.
    ; Ahmed A; Waagstein F; Pitt B; White M; Zannad F; Young JB; Rahimtoola SH
    Am J Cardiol; 2009 Jan; 103(1):82-7. PubMed ID: 19101235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose response characterization of the association of serum digoxin concentration with mortality outcomes in the Digitalis Investigation Group trial.
    Adams KF; Butler J; Patterson JH; Gattis Stough W; Bauman JL; van Veldhuisen DJ; Schwartz TA; Sabbah H; Mackowiak JI; Ventura HO; Ghali JK
    Eur J Heart Fail; 2016 Aug; 18(8):1072-81. PubMed ID: 27492641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalent digoxin use and subsequent risk of death or hospitalization in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) randomized controlled trial.
    Ambrosy AP; Bhatt AS; Stebbins AL; Wruck LM; Fudim M; Greene SJ; Kraus WE; O'Connor CM; Piña IL; Whellan DJ; Mentz RJ
    Am Heart J; 2018 May; 199():97-104. PubMed ID: 29754673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can available mathematical models predict serum digoxin levels in Thai patients?
    Jiratham-Opas J; Kanjanavanit R; Wongcharoen W; Punyawudho B; Arunmanakul P; Amaritakomol A; Topaiboon P; Gunaparn S; Phrommintikul A
    J Clin Pharm Ther; 2018 Jun; 43(3):377-384. PubMed ID: 29365353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Autoantibody against M2-Muscarinic Acetylcholine Receptor in Heart Failure Patients on Digoxin Treatment.
    Hou D; Fan Z; Xu L; Wang H; Zhang Z; Ma G; Xu X; Wang X; Zhang J; Liu J; Zhang L
    Cardiology; 2018; 141(1):9-17. PubMed ID: 30293082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of serum concentration-guided digoxin therapy on mortality of heart failure patients: A long-term follow-up, propensity-matched cohort study.
    Muk B; Vámos M; Bógyi P; Szabó B; Dékány M; Vágány D; Majoros Z; Borsányi T; Duray GZ; Kiss RG; Nyolczas N
    Clin Cardiol; 2020 Dec; 43(12):1641-1648. PubMed ID: 33140454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of OATP1B1 and OATP1B3 mutations and glomerular filtration rate on trough serum digoxin concentration in the Chinese population: A prospective cohort study.
    Chen SQ; Ding WH; Zhang N; Xiang Q; Cui YM; Zhao X
    Medicine (Baltimore); 2019 Apr; 98(14):e15088. PubMed ID: 30946364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is foxglove effective in heart failure?
    Chaggar PS; Shaw SM; Williams SG
    Cardiovasc Ther; 2015 Aug; 33(4):236-41. PubMed ID: 25925484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ivabradine in Children With Dilated Cardiomyopathy and Symptomatic Chronic Heart Failure.
    Bonnet D; Berger F; Jokinen E; Kantor PF; Daubeney PEF
    J Am Coll Cardiol; 2017 Sep; 70(10):1262-1272. PubMed ID: 28859790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digoxin therapy and associated clinical outcomes in the MADIT-CRT trial.
    Lee AY; Kutyifa V; Ruwald MH; McNitt S; Polonsky B; Zareba W; Moss AJ; Ruwald AC
    Heart Rhythm; 2015 Sep; 12(9):2010-7. PubMed ID: 26025322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of digoxin in patients with heart failure and reduced ejection fraction according to diabetes status: An analysis of the Digitalis Investigation Group (DIG) trial.
    Abdul-Rahim AH; MacIsaac RL; Jhund PS; Petrie MC; Lees KR; McMurray JJ;
    Int J Cardiol; 2016 Apr; 209():310-6. PubMed ID: 26913372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic drug monitoring of digoxin-20 years of experience.
    Grześk G; Stolarek W; Kasprzak M; Krzyżanowski M; Szadujkis-Szadurska K; Wiciński M; Grześk E
    Pharmacol Rep; 2018 Feb; 70(1):184-189. PubMed ID: 29414149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial.
    Gheorghiade M; Patel K; Filippatos G; Anker SD; van Veldhuisen DJ; Cleland JG; Metra M; Aban IB; Greene SJ; Adams KF; McMurray JJ; Ahmed A
    Eur J Heart Fail; 2013 May; 15(5):551-9. PubMed ID: 23355060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study.
    Pieske B; Maggioni AP; Lam CSP; Pieske-Kraigher E; Filippatos G; Butler J; Ponikowski P; Shah SJ; Solomon SD; Scalise AV; Mueller K; Roessig L; Gheorghiade M
    Eur Heart J; 2017 Apr; 38(15):1119-1127. PubMed ID: 28369340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial Effect on Surrogate Markers of Heart Failure with Bisoprolol Up-Titration to Recommended Targets in Korean Patients with Heart Failure and Left Ventricular Systolic Dysfunction.
    Han SW; Choi SW; Ryu KH; Kim HJ; Kim SH; Shim WJ; Cha TJ; Choi DJ; Kim YJ; Yoo BS; Kim JH; Hwang KK; Jeon H; Shin MS
    Cardiovasc Ther; 2016 Jun; 34(3):172-9. PubMed ID: 27003232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure: The ATOMIC-AHF Study.
    Teerlink JR; Felker GM; McMurray JJV; Ponikowski P; Metra M; Filippatos GS; Ezekowitz JA; Dickstein K; Cleland JGF; Kim JB; Lei L; Knusel B; Wolff AA; Malik FI; Wasserman SM;
    J Am Coll Cardiol; 2016 Mar; 67(12):1444-1455. PubMed ID: 27012405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of Digoxin Improves Cardiac Function in Children With the Dilated Cardiomyopathy With Ataxia Syndrome: A Mitochondrial Cardiomyopathy.
    Greenway SC; Dallaire F; Hazari H; Patel D; Khan A
    Can J Cardiol; 2018 Aug; 34(8):972-977. PubMed ID: 29887217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart Failure With Improved Ejection Fraction: Clinical Characteristics, Correlates of Recovery, and Survival: Results From the Valsartan Heart Failure Trial.
    Florea VG; Rector TS; Anand IS; Cohn JN
    Circ Heart Fail; 2016 Jul; 9(7):. PubMed ID: 27413037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.